The invention relates to clinical chemistry, in particular, to new biologically active compounds amide derivatives of prostaglandin F2α. These compounds have low cytotoxicity and are capable of stimulating formation of endogenous nitrogen oxide in mammal cells. Synthesis of such compounds promotes expansion of nomenclature of biologically active derivatives of prostaglandin F2α capable of reducing intraocular pressure.
这项发明涉及临床
化学,特别是新的
生物活性化合物——
前列腺素F2α酰胺衍
生物。这些化合物具有低细胞毒性,并能够刺激哺乳动物细胞内源性
一氧化氮的形成。合成这类化合物有助于扩展能够降低眼内压的
生物活性
前列腺素F2α衍
生物的命名。